Isolation and Charactrization of Neurokinin a Receptor cDNAs from Guinea-Pig Lung and Rabbit Pulmonary Artery

References

• Maggi C. A., Patacchini R., Rovero P., Giachetti A. Tachykinin receptors and tachykinin receptor antagonists. J. Auton. Pharmacol. 1993; 13: 23–93
   PubMedGoogle Scholar
• Masu Y., Nakayama K., Tamaki H., Harada Y., Kuno M., Nakanishi S. cDNA cloning of bovine substance-K receptor through oocyte expression system. Nature (Lond.) 1987; 329: 836–838
   PubMed Web of Science ®Google Scholar
• Gerard N. P., Eddy R. L., Shows T. B., Gerard C. The human neurokinin A (substance K) receptor. J. Biol. Chem. 1990; 265: 20455–20462
   PubMed Web of Science ®Google Scholar
• Kris R. M., South V., Saltzman A., Felder S., Ricca G. A., Jaye M., Huebner K., Kagan J., Croce C. M., Schlessinger J. Cloning and expression of human substance-K receptor and analysis of its role in mitogenesis. Cell Growth and Differ. 1991; 2: 15–22
   PubMedGoogle Scholar
• Graham A., Hopkins B., Powell S. J., Danks P., Briggs I. Isolation and characterization of human lung NK-2 receptor gene using rapid amplification of cDNA ends. Biochem. Biophys. Res. Comm. 1991; 177: 8–16
   PubMed Web of Science ®Google Scholar
• Sasai Y., Nakanishi S. Molecular characterization of rat substance K receptor and its mRNAs. Biochem. Biophys. Res. Comm. 1989; 165: 695–702
   PubMed Web of Science ®Google Scholar
• Aharony D., Little J., Thomas C., Powell S., Berry D., Graham A. Isolation and pharmacological characterization of a hamster neurokinin A receptor cDNA. Mol. Pharmacol. 1994; 45: 9–19
   PubMed Web of Science ®Google Scholar
• Yokota Y., Akazawa C., Ohkubo H., Nakanishi S. Delineation of structural domains involved in the subtype specificity of tachykinin receptors through chimeric formation of substance P/substance K receptors. EMBO J. 1992; 11: 3585–3591
   PubMed Web of Science ®Google Scholar
• Fong T. M., Huang R.-R. C., Strader C. D. Localization of agonist and antagonist binding domains of the human neurokinin 1 receptor. J. Biol. Chem. 1992; 267: 25664–25667
   PubMed Web of Science ®Google Scholar
• Fong T. M., Yu H., Strader C. D. Molecular basis for the species selectivity of the neurokinin 1 receptor antagonists CP-96,345 and RP67580. J. Biol. Chem. 1992; 267: 25668–25671
   PubMed Web of Science ®Google Scholar
• Sachais B. S., Snider R. M., Lowe J. A., III, Krause J. E. Molecular basis for the species selectivity of the substance P antagonist CP-96,345. J. Biol. Chem. 1993; 268: 2319–2323
   PubMed Web of Science ®Google Scholar
• Aharony D., Little J., Powell S., Hopkins B., Bundell K. R., McPheat W. L., Gordon R., Hassall G., Hockney R., Griffin R., Graham A. Pharmacological characterization of cloned human neurokinin A (NK-2) receptor expressed in a baculovirus-Sf21 insect cell system. Mol. Pharmacol. 1993; 44: 356–363
   PubMed Web of Science ®Google Scholar
• Chirgwin J. M., Przbyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–5299
   PubMed Web of Science ®Google Scholar
• Frohman M. A., Dush M. K., Martin G. R. Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA 1988; 85: 8998–9002
   PubMed Web of Science ®Google Scholar
• Frohman M. A., Martin G. R. Rapid amplification of cDNA ends using nested primers. Technique 1990; 1: 165–170
   Google Scholar
• Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487–494
   PubMed Web of Science ®Google Scholar
• Newton C. R., Kalsheker N., Graham A., Powell S., Gammack A. J., Riley J., Markham A. F. Diagnosis of a-1-antitrypsin deficiency by enzymatic amplification of human genomic DNA and direct sequencing of polymerase chain reaction products. Nucl. Acids Res. 1988; 16: 8233–8243
   PubMed Web of Science ®Google Scholar
• Needham M., Egerton M., Millest A., Evans S., Popplewell M., Cerillo G., McPheat J., Monk A., Jack A., Johnstone D., Hollis M. Further development of the LCR/MEL expression system: high level expression and characterization of recombinant human calcitonin receptor, (submitted)
   Google Scholar
• Needham M., Gooding C., Hudson K., Antoniou M., Grosveld F., Hollis M. LCR/MEL: A versatile system for high-level expression of heterologous proteins in erythroid cells. Nucleic Acids Res. 1992; 20: 997–1003
   PubMed Web of Science ®Google Scholar
• Hawkins E. F. AccuFit Saturation-Two site: A new program for rapid and automated analysis of data from receptor saturation assays. Beckman Technical Information Bulletin: T-1666-NUC-89–4, 1989
   Google Scholar
• Feldman H. A. Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting. Anal. Biochem. 1972; 48: 317–338
   PubMed Web of Science ®Google Scholar
• Aharony D., Conner G. E., Woodhouse D. P. Pharmacologic characterization of binding of the novel ligand [4,5-3H-Leu9]-Neurokinin A to NK-2 receptors on hamster urinary bladder membranes. Neuropeptides 1992; 23: 121–130
   PubMed Web of Science ®Google Scholar
• Geraghty D. P., Mussap C. J., Burcher E. Radioiodinated substance P, neurokinin A and eledoisin bind predominantly to NK-1 receptors in guinea pig lung. Mol. Pharmacol. 1992; 41: 147–153
   PubMed Web of Science ®Google Scholar
• Xiao X. H., Mussap C. J., Burcher E. Characterization of the tachykinin NK2 receptor subtypes in the rabbit pulmonary artery. Peptides 1992; 132: 281–285
   Google Scholar
• McKee K. T., Millar L., Rodger I. W., Metters K. M. Identification of both NK1 and NK2 receptors in guinea pig airways. Br. J. Pharmacol. 1993; 110: 693–700
   PubMed Web of Science ®Google Scholar
• Zeng X.-P., Lavielle S., Burcher E. Evidence for NK-2 receptors in guinea-pig airways from binding and functional studies, using [125I]-[Lys5], Tyr(I2)7, MeLeu9Nle10]-NKA(4–10). Neuropeptides 1994; 26: 1–9
   PubMed Web of Science ®Google Scholar
• Grisshammer R., Little J., Aharony D. Pharmacological Characterization of Rat NK-2 (Neurokinin A) Receptor Expressed in Escherichia Coli. J. receptors and Channels., accepted in
   Google Scholar
• Ellis J. L., Undem B. J., Kay J. S., Ghanekar S. V., Barthlow H. G., Buckner C. K. Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster. J. Pharmcol. Exper. Ther. 1993; 267: 95–101
   PubMed Web of Science ®Google Scholar
• Maggi C. A., Patacchini R., Giuliani S., Giachetti A. In vivo and in vitro pharmacology of SR48,968, a non-peptide tachykinin NK2 receptor antagonist. Eur. J. Pharmacol. 1993; 234: 83–90
   PubMed Web of Science ®Google Scholar
• Strader C. D., Sigal I. S., Dixon R. A.F. Structural basis of β-adrenergic receptor function. FASEB J. 1992; 3: 1825–1832
   Google Scholar
• Khorana H. G. Rhodopsin, photoreceptor of the rod cell. J. Biol. Chem. 1992; 267: 1–4
   PubMed Web of Science ®Google Scholar
• Oksenberg D., Marsters S. A., O'Dowd B. F., Jin H., Havlik S., Peroutka S. J., Ashkenazi A. A single amino acid difference confers major pharmacological variation between human and rodent 5-HT 1B receptors. Nature 1992; 360: 161–163
   PubMed Web of Science ®Google Scholar
• Sloane D. L., Leung R., Craik C. S., Sigal E. A primary determinant for lipoxygenase positional specificity. Nature 1991; 354: 149–152
   PubMed Web of Science ®Google Scholar